* We recommend a score >= 0.08 for meaningful Gene-Disease associations
GeneID | Gene_Symbol | DisGeNet_diseaseID | Disease_name | ![]() | DisGeNet_sourceDB |
1111 | CHEK1 | C1458155 | Mammary Neoplasms | 0.200549453568426 | BEFREE;CTD_human |
1111 | CHEK1 | C0032578 | Polyploidy | 0.2 | CTD_human |
1111 | CHEK1 | C0036341 | Schizophrenia | 0.2 | PSYGENET |
1111 | CHEK1 | C0006142 | Malignant neoplasm of breast | 0.0204861603924162 | BEFREE;GAD |
1111 | CHEK1 | C0015625 | Fanconi Anemia | 0.010121824883933 | BEFREE;LHGDN |
1111 | CHEK1 | C0678222 | Breast Carcinoma | 0.0065934428211144 | BEFREE |
1111 | CHEK1 | C0242379 | Malignant neoplasm of lung | 0.0059129641834284 | BEFREE;GAD |
1111 | CHEK1 | C0009375 | Colonic Neoplasms | 0.00513994098810175 | GAD;LHGDN |
1111 | CHEK1 | C0012860 | DNA Damage | 0.004814057046576 | GAD |
1111 | CHEK1 | C1527249 | Colorectal Cancer | 0.0043301160127797 | BEFREE;GAD |
1111 | CHEK1 | C2239176 | Liver carcinoma | 0.00410654638587925 | BEFREE;LHGDN |
1111 | CHEK1 | C0017638 | Glioma | 0.0035059356601404 | BEFREE;GAD |
1111 | CHEK1 | C0029463 | Osteosarcoma | 0.00328236603323995 | BEFREE;LHGDN |
1111 | CHEK1 | C0004135 | Ataxia Telangiectasia | 0.0030219946263441 | BEFREE |
1111 | CHEK1 | C0025958 | Microcephaly | 0.00300763924902685 | BEFREE;LHGDN |
1111 | CHEK1 | C0033578 | Prostatic Neoplasms | 0.00300763924902685 | BEFREE;LHGDN |
1111 | CHEK1 | C0005684 | Malignant neoplasm of urinary bladder | 0.0029564820917142 | BEFREE;GAD |
1111 | CHEK1 | C0009404 | Colorectal Neoplasms | 0.00273291246481375 | LHGDN |
1111 | CHEK1 | C0024305 | Lymphoma, Non-Hodgkin | 0.00273291246481375 | LHGDN |
1111 | CHEK1 | C0027859 | Acoustic Neuroma | 0.0026817553075011 | BEFREE;GAD |
1111 | CHEK1 | C0677886 | Epithelial ovarian cancer | 0.0026817553075011 | BEFREE;GAD |
1111 | CHEK1 | C0029925 | Ovarian Carcinoma | 0.0024725410579179 | BEFREE |
1111 | CHEK1 | C0006118 | Brain Neoplasms | 0.002407028523288 | GAD |
1111 | CHEK1 | C0024117 | Chronic Obstructive Airway Disease | 0.002407028523288 | GAD |
1111 | CHEK1 | C0025286 | Meningioma | 0.002407028523288 | GAD |
1111 | CHEK1 | C0030297 | Pancreatic Neoplasm | 0.002407028523288 | GAD |
1111 | CHEK1 | C0887833 | Carcinoma, Pancreatic Ductal | 0.002407028523288 | GAD |
1111 | CHEK1 | C0920269 | Microsatellite Instability | 0.002407028523288 | GAD |
1111 | CHEK1 | C0007102 | Malignant tumor of colon | 0.0021978142737048 | BEFREE |
1111 | CHEK1 | C0235974 | Pancreatic carcinoma | 0.0021978142737048 | BEFREE |
1111 | CHEK1 | C0596263 | Carcinogenesis | 0.0021978142737048 | BEFREE |
1111 | CHEK1 | C0009402 | Colorectal Carcinoma | 0.0019230874894917 | BEFREE |
1111 | CHEK1 | C0023418 | leukemia | 0.0019230874894917 | BEFREE |
1111 | CHEK1 | C0023467 | Leukemia, Myelocytic, Acute | 0.0019230874894917 | BEFREE |
1111 | CHEK1 | C0025202 | melanoma | 0.0019230874894917 | BEFREE |
1111 | CHEK1 | C0346647 | Malignant neoplasm of pancreas | 0.0019230874894917 | BEFREE |
1111 | CHEK1 | C0699790 | Colon Carcinoma | 0.0019230874894917 | BEFREE |
1111 | CHEK1 | C1140680 | Malignant neoplasm of ovary | 0.0019230874894917 | BEFREE |
1111 | CHEK1 | C3469521 | FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | 0.0016483607052786 | BEFREE |
1111 | CHEK1 | C3539878 | Triple Negative Breast Neoplasms | 0.0016483607052786 | BEFREE |
1111 | CHEK1 | C0007131 | Non-Small Cell Lung Carcinoma | 0.0013736339210655 | BEFREE |
1111 | CHEK1 | C0024299 | Lymphoma | 0.0013736339210655 | BEFREE |
1111 | CHEK1 | C0024623 | Malignant neoplasm of stomach | 0.0010989071368524 | BEFREE |
1111 | CHEK1 | C0026764 | Multiple Myeloma | 0.0010989071368524 | BEFREE |
1111 | CHEK1 | C0280100 | solid tumor | 0.0010989071368524 | BEFREE |
1111 | CHEK1 | C0302592 | Cervix carcinoma | 0.0010989071368524 | BEFREE |
1111 | CHEK1 | C0684249 | Carcinoma of lung | 0.0010989071368524 | BEFREE |
1111 | CHEK1 | C1306460 | Primary malignant neoplasm of lung | 0.0010989071368524 | BEFREE |
1111 | CHEK1 | C0002395 | Alzheimer's Disease | 0.0008241803526393 | BEFREE |
1111 | CHEK1 | C0376358 | Malignant neoplasm of prostate | 0.0008241803526393 | BEFREE |
1111 | CHEK1 | C0600139 | Prostate carcinoma | 0.0008241803526393 | BEFREE |
1111 | CHEK1 | C0699791 | Stomach Carcinoma | 0.0008241803526393 | BEFREE |
1111 | CHEK1 | C2931822 | Nasopharyngeal carcinoma | 0.0008241803526393 | BEFREE |
1111 | CHEK1 | C0005695 | Bladder Neoplasm | 0.0005494535684262 | BEFREE |
1111 | CHEK1 | C0007137 | Squamous cell carcinoma | 0.0005494535684262 | BEFREE |
1111 | CHEK1 | C0007847 | Malignant tumor of cervix | 0.0005494535684262 | BEFREE |
1111 | CHEK1 | C0027819 | Neuroblastoma | 0.0005494535684262 | BEFREE |
1111 | CHEK1 | C0035335 | Retinoblastoma | 0.0005494535684262 | BEFREE |
1111 | CHEK1 | C0085390 | Li-Fraumeni Syndrome | 0.0005494535684262 | BEFREE |
1111 | CHEK1 | C0149925 | Small cell carcinoma of lung | 0.0005494535684262 | BEFREE |
1111 | CHEK1 | C0262584 | Carcinoma, Small Cell | 0.0005494535684262 | BEFREE |
1111 | CHEK1 | C0332996 | Persistent embryonic structure | 0.0005494535684262 | BEFREE |
1111 | CHEK1 | C0334634 | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 0.0005494535684262 | BEFREE |
1111 | CHEK1 | C0585442 | Osteosarcoma of bone | 0.0005494535684262 | BEFREE |
1111 | CHEK1 | C0699885 | Carcinoma of bladder | 0.0005494535684262 | BEFREE |
1111 | CHEK1 | C0700095 | Central neuroblastoma | 0.0005494535684262 | BEFREE |
1111 | CHEK1 | C4048328 | cervical cancer | 0.0005494535684262 | BEFREE |
1111 | CHEK1 | C0001418 | Adenocarcinoma | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0001486 | Adenovirus Infections | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0002871 | Anemia | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0002894 | Refractory anaemia with excess blasts | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0004096 | Asthma | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0004134 | Ataxia | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0006840 | Candidiasis | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0007103 | Malignant neoplasm of endometrium | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0007124 | Noninfiltrating Intraductal Carcinoma | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0007134 | Renal Cell Carcinoma | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0007758 | Cerebellar Ataxia | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0008626 | Congenital chromosomal disease | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0009207 | Cockayne Syndrome | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0023449 | Acute lymphocytic leukemia | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0023470 | Myeloid Leukemia | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0023827 | liposarcoma | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0024121 | Lung Neoplasms | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0024301 | Lymphoma, Follicular | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0025007 | Measles | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0025500 | Mesothelioma | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0027019 | Myelomonocytic leukemia | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0027627 | Neoplasm Metastasis | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0028754 | Obesity | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0032580 | Adenomatous Polyposis Coli | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0032927 | Precancerous Conditions | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0033036 | Atrial Premature Complexes | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0038356 | Stomach Neoplasms | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0042769 | Virus Diseases | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0043346 | Xeroderma Pigmentosum | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0079731 | B-Cell Lymphomas | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0085669 | Acute leukemia | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0151747 | Renal tubular disorder | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0152013 | Adenocarcinoma of lung (disorder) | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0153252 | Systemic candidiasis | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0153633 | Malignant neoplasm of brain | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0178874 | Tumor Progression | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0206708 | Cervical Intraepithelial Neoplasia | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0238033 | Carcinoma of Male Breast | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0238463 | Papillary thyroid carcinoma | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0242787 | Malignant neoplasm of male breast | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0265202 | Seckel syndrome | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0267963 | Exocrine pancreatic insufficiency | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0278996 | Cancer of Head and Neck | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0279626 | Squamous cell carcinoma of esophagus | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0333516 | Tumor necrosis | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0334108 | Multiple polyps | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0346153 | Breast Cancer, Familial | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0424295 | Hyperactive behavior | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0476089 | Endometrial Carcinoma | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0686619 | Secondary malignant neoplasm of lymph node | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C0854778 | Resectable Pancreatic Carcinoma | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C1168327 | High-Grade Prostatic Intraepithelial Neoplasia | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C1266129 | Atypical Lipoma | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C1334274 | Invasive Carcinoma | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C1334634 | Mature B-Cell Non-Hodgkin Lymphoma | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C1512981 | Mammary Tumorigenesis | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C1559154 | Rash and Dermatitis Adverse Event Associated with Chemoradiation | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C1883486 | Uterine Corpus Cancer | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C1955934 | Trichothiodystrophy Syndromes | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C1961099 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C1961102 | Precursor Cell Lymphoblastic Leukemia Lymphoma | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C3463824 | MYELODYSPLASTIC SYNDROME | 0.0002747267842131 | BEFREE |
1111 | CHEK1 | C3887505 | DYSFUNCTION - SKIN DISORDERS | 0.0002747267842131 | BEFREE |